Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Coyle

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Acta Neuropathologica|November 24, 2011
Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and deathHazel A Rogers, John-Paul Kilday, Cerys Mayne, et al.
Acta Neuropathologica Communications|June 3, 2014
Overcoming multiple drug resistance mechanisms in medulloblastomaRamadhan T Othman, Ioanna Kimishi, Tracey D Bradshaw, et al.
Neuro-Oncology|August 15, 2008
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymomaLee Ridley, Ruman Rahman, Marie-Anne Brundler, et al.
ACS Applied Materials & Interfaces|July 26, 2021
Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl AnalogueVahid Heravi Shargh, Jeni Luckett, Kaouthar Bouzinab, et al.
Neuro-Oncology|July 30, 2011
Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastomaSuzanne Miller, Hazel A Rogers, Paul Lyon, et al.
Neuro-Oncology Advances|January 6, 2022
Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.
Neuro-Oncology Advances|May 5, 2021
ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP)John-Paul Kilday, Biswaroop Mitra, Caroline Domerg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult diseaseBarbara S Paugh, Chunxu Qu, Chris Jones, et al.
Human Cell|February 17, 2025
Immunomodulatory role of exosome-derived content in pediatric medulloblastoma: a molecular subgroup perspectiveJessica Oliveira de Santis, Graziella Ribeiro de Sousa, Rosane Gomes de Paula Queiroz, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Acta Neuropathologica|November 24, 2011
Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and deathHazel A Rogers, John-Paul Kilday, Cerys Mayne, et al.
Acta Neuropathologica Communications|June 3, 2014
Overcoming multiple drug resistance mechanisms in medulloblastomaRamadhan T Othman, Ioanna Kimishi, Tracey D Bradshaw, et al.
Neuro-Oncology|August 15, 2008
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymomaLee Ridley, Ruman Rahman, Marie-Anne Brundler, et al.
ACS Applied Materials & Interfaces|July 26, 2021
Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl AnalogueVahid Heravi Shargh, Jeni Luckett, Kaouthar Bouzinab, et al.
Neuro-Oncology|July 30, 2011
Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastomaSuzanne Miller, Hazel A Rogers, Paul Lyon, et al.
Neuro-Oncology Advances|January 6, 2022
Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.
Neuro-Oncology Advances|May 5, 2021
ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP)John-Paul Kilday, Biswaroop Mitra, Caroline Domerg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult diseaseBarbara S Paugh, Chunxu Qu, Chris Jones, et al.
Human Cell|February 17, 2025
Immunomodulatory role of exosome-derived content in pediatric medulloblastoma: a molecular subgroup perspectiveJessica Oliveira de Santis, Graziella Ribeiro de Sousa, Rosane Gomes de Paula Queiroz, et al.
Pageof 5